Apr 10 |
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
|
Apr 3 |
Navigating 6 Analyst Ratings For Pulmonx
|
Mar 26 |
Pulmonx: Revisiting Thesis Following Management Change
|
Mar 15 |
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
Mar 1 |
Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp
|
Feb 26 |
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
|
Feb 24 |
US$16.50 - That's What Analysts Think Pulmonx Corporation (NASDAQ:LUNG) Is Worth After These Results
|
Feb 23 |
Pulmonx dips on Wells Fargo downgrade eyeing uncertainty over management changes
|
Feb 23 |
Analyst Ratings For Pulmonx
|
Feb 23 |
Pulmonx Full Year 2023 Earnings: Beats Expectations
|